CLINICAL UTILITY OF NEXT-GENERATION SEQUENCING IN HEMATOLOGIC MALIGNANCIES: INTEGRATING MOLECULAR DIAGNOSIS, MEASURABLE RESIDUAL DISEASE, AND INFECTION DIAGNOSTICS IN IMMUNOCOMPROMISED PATIENTS

Chronic kidney disease (CKD) remains a major health burden worldwide. Identifying people at risk earlier may allow timely intervention and help slow disease progression. However, many machine-learning studies focus mainly on accuracy and give less attention to model stability, formal statistical comparisons, calibration, and clinical interpretability. We compared Logistic Regression, Random Forest, and XGBoost for CKD prediction and examined how the models compared in calibration, interpretability, and estimated clinical utility. We analyzed the UCI CKD dataset (400 records, 24 predictors). A stratified 80:20 training-test split was created, and all preprocessing steps were embedded within the modeling pipeline to prevent information leakage. Performance was assessed using accuracy, precision, recall, F1-score, and ROC-AUC, along with repeated stratified five-fold cross-validation (10 repetitions). We also estimated bootstrap confidence intervals, examined calibration, generated SHAP-based explanations, and performed decision-curve analysis. Model differences were tested with the Friedman test, followed by paired Wilcoxon signed-rank tests with Holm adjustment. Random Forest and XGBoost produced no classification errors in the held-out test set, whereas Logistic Regression misclassified one CKD case, yielding 98.8% accuracy. In repeated cross-validation, mean accuracy was 99.5% for Logistic Regression, 99.1% for Random Forest, and 98.3% for XGBoost (Friedman p < 0.001). SHAP analyses consistently identified hemoglobin, specific gravity, serum creatinine, packed cell volume, and red blood cell count as among the strongest predictors. All three models performed strongly, although Logistic Regression offered greater simplicity and interpretability. These findings require confirmation in larger, independent clinical cohorts before the models can be considered for routine use.

Authors

Publication Details

Journal
Acta Innovations
Published
2026-11-03
DOI
https://doi.org/10.62441/actainnovations.vi.3030
Primary Topic
Acute Lymphoblastic Leukemia research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CLINICAL UTILITY OF NEXT-GENERATION SEQUENCING IN HEMATOLOGIC MALIGNANCIES: INTEGRATING MOLECULAR DIAGNOSIS, MEASURABLE RESIDUAL DISEASE, AND INFECTION DIAGNOSTICS IN IMMUNOCOMPROMISED PATIENTS

Mariem Baazaoui, Ola Alkhuffash
Acta Innovations
Acute Lymphoblastic Leukemia research
article

CLINICAL UTILITY OF NEXT-GENERATION SEQUENCING IN HEMATOLOGIC MALIGNANCIES: INTEGRATING MOLECULAR DIAGNOSIS, MEASURABLE RESIDUAL DISEASE, AND INFECTION DIAGNOSTICS IN IMMUNOCOMPROMISED PATIENTS

Mariem Baazaoui, Ola Alkhuffash
article en

Abstract

Chronic kidney disease (CKD) remains a major health burden worldwide. Identifying people at risk earlier may allow timely intervention and help slow disease progression. However, many machine-learning studies focus mainly on accuracy and give less attention to model stability, formal statistical comparisons, calibration, and clinical interpretability. We compared Logistic Regression, Random Forest, and XGBoost for CKD prediction and examined how the models compared in calibration, interpretability, and estimated clinical utility. We analyzed the UCI CKD dataset (400 records, 24 predictors). A stratified 80:20 training-test split was created, and all preprocessing steps were embedded within the modeling pipeline to prevent information leakage. Performance was assessed using accuracy, precision, recall, F1-score, and ROC-AUC, along with repeated stratified five-fold cross-validation (10 repetitions). We also estimated bootstrap confidence intervals, examined calibration, generated SHAP-based explanations, and performed decision-curve analysis. Model differences were tested with the Friedman test, followed by paired Wilcoxon signed-rank tests with Holm adjustment. Random Forest and XGBoost produced no classification errors in the held-out test set, whereas Logistic Regression misclassified one CKD case, yielding 98.8% accuracy. In repeated cross-validation, mean accuracy was 99.5% for Logistic Regression, 99.1% for Random Forest, and 98.3% for XGBoost (Friedman p < 0.001). SHAP analyses consistently identified hemoglobin, specific gravity, serum creatinine, packed cell volume, and red blood cell count as among the strongest predictors. All three models performed strongly, although Logistic Regression offered greater simplicity and interpretability. These findings require confirmation in larger, independent clinical cohorts before the models can be considered for routine use.

Acta InnovationsVol. 64(2s)
Openalex Percentile: Top 12%
Acute Lymphoblastic Leukemia research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
CLINICAL UTILITY OF NEXT-GENERATION SEQUENCING IN HEMATOLOGIC MALIGNANCIES: INTEGRATING MOLECULAR DIAGNOSIS, MEASURABLE RESIDUAL DISEASE, AND INFECTION DIAGNOSTICS IN IMMUNOCOMPROMISED PATIENTS — Mariem Baazaoui, Ola Alkhuffash · Acta Innovations (2026) | TGRS Research Map | TGRS